Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes

Citations

WEB OF SCIENCE

0
제목
Survival Benefit with Standard-Dose Decitabine Versus Standard-Dose Azacitidine in Patients with Lower-Risk Myelodysplastic Syndromes
저자
Lee, Byung-HyunKang, Ka-WonJeon, Min JiYu, Eun SangKim, Dae SikChoi, HojoonLee, Se RyunSung, Hwa JungPark, YongChoi, Chul WonKim, Byung Soo
DOI
10.1182/blood-2018-99-115694
발행일
2018-11-29
유형
Meeting Abstract
저널명
Blood
132